Physician profile
Meredith T Mann
NPI 1992930333
$617.36
in general payments reported to CMS, 2019-2025
15 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.32 · 2020: $39.74 · 2021: $47.90 · 2023: $151 · 2024: $44.69 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.41 |
| Education | $173.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $203.12 | 2024-2025 | Veozah |
| Depuy Synthes Sales INC. | $109.01 | 2020-2023 | Matrixmandible |
| Applied Medical Resources Corporation | $73.16 | 2023 | Gelpoint V-Path |
| Biogen, INC. | $37.49 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $33.97 | 2019-2023 | Summit Doppler |
| Mindray Ds USA, INC. | $26.55 | 2023 | Te X, Te7 Max |
| Exact Sciences Corporation | $21.11 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $18.25 | 2019 | |
| Pfizer INC. | $15.75 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.17 | 2019 | |
| Innovation Technologies INC | $14.45 | 2025 | Irrisept |
| Molnlycke Health Care US, LLC | $13.00 | 2025 | Avance, Mepilex Border Post-Op Ag |
| Kci USA, INC. | $12.91 | 2021 | |
| Abbvie INC. | $12.34 | 2019 | |
| Covidien LP | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.